These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28073181)

  • 1. Participation restrictions in ambulatory amyotrophic lateral sclerosis patients: Physical and psychological factors.
    Van Groenestijn AC; Schröder CD; Kruitwagen-Van Reenen ET; Van Den Berg LH; Visser-Meily JMA
    Muscle Nerve; 2017 Nov; 56(5):912-918. PubMed ID: 28073181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis.
    Sandstedt P; Johansson S; Ytterberg C; Ingre C; Holmqvist LW; Kierkegaard M
    J Neurol Sci; 2016 Nov; 370():269-273. PubMed ID: 27772773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group.
    McGuire D; Garrison L; Armon C; Barohn R; Bryan W; Miller R; Parry G; Petajan J; Ross M
    Neurology; 1996 May; 46(5):1442-4. PubMed ID: 8628496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation and autonomy in the first 10 months after diagnosis of ALS: a longitudinal study.
    Kruitwagen-Van Reenen ET; Scholten EWM; van Groenestijn A; Van Den Berg LH; Post MWM; Visser-Meily J
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):459-466. PubMed ID: 33683160
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies.
    Damiano AM; Patrick DL; Guzman GI; Gawel MJ; Gelinas DF; Natter HM; Ingalls KK
    Med Care; 1999 Jan; 37(1):15-26. PubMed ID: 10413388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usability of eyetracking computer systems and impact on psychological wellbeing in patients with advanced amyotrophic lateral sclerosis.
    Linse K; Rüger W; Joos M; Schmitz-Peiffer H; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):212-219. PubMed ID: 29092645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation.
    Hunter MD; Robinson IC; Neilson S
    Disabil Rehabil; 1993; 15(3):119-26. PubMed ID: 8374156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis.
    Neudert C; Wasner M; Borasio GD
    J Palliat Med; 2004 Aug; 7(4):551-7. PubMed ID: 15353099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary ALS care improves quality of life in patients with ALS.
    Van den Berg JP; Kalmijn S; Lindeman E; Veldink JH; de Visser M; Van der Graaff MM; Wokke JH; Van den Berg LH
    Neurology; 2005 Oct; 65(8):1264-7. PubMed ID: 16247055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability and Contextual Factors in Patients with Amyotrophic Lateral Sclerosis - A Three-Year Observational Study.
    Sandstedt P; Littorin S; Johansson S; Gottberg K; Ytterberg C; Kierkegaard M
    J Neuromuscul Dis; 2018; 5(4):439-449. PubMed ID: 30282373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of physical impairment on emotional well-being in ALS.
    Abdulla S; Vielhaber S; Kollewe K; Machts J; Heinze HJ; Dengler R; Petri S
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):392-7. PubMed ID: 25008979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between illness cognitions and health-related quality of life in the first year after diagnosis of amyotrophic lateral sclerosis.
    Kruitwagen-van Reenen ETH; Post MWM; van Groenestijn A; van den Berg LH; Visser-Meily JMA
    J Psychosom Res; 2020 May; 132():109974. PubMed ID: 32155469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
    Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Pain and Functional Status in Patients with Amyotrophic Lateral Sclerosis: A Multicenter Cross-Sectional Study.
    Ishida N; Hongo S; Kumano A; Hatta H; Zakoji N; Hirutani M; Yamamoto Y; Aono H; Tuigi M; Suzuki R; Hanamitsu H; Wakasugi E; Takahashi M; Yamatani A
    J Palliat Med; 2018 May; 21(5):588-591. PubMed ID: 29319397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in ALS depends on factors other than strength and physical function.
    Simmons Z; Bremer BA; Robbins RA; Walsh SM; Fischer S
    Neurology; 2000 Aug; 55(3):388-92. PubMed ID: 10932273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index.
    De Groot IJ; Post MW; Van Heuveln T; Van Den Berg LH; Lindeman E
    Amyotroph Lateral Scler; 2006 Sep; 7(3):167-72. PubMed ID: 16963406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
    Ben Ari Shevil E; Johansson S; Ytterberg C; Bergström J; von Koch L
    Disabil Rehabil; 2014; 36(23):2012-8. PubMed ID: 24524439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of rate and pause features to the communicative participation of people living with ALS.
    Connaghan KP; Green JR; Eshghi M; Haenssler AE; Scheier ZA; Clark A; Iyer A; Richburg BD; Rowe HP; Okada J; Johnson SA; Onnela JP; Burke KM; Berry JD
    Muscle Nerve; 2024 Aug; 70(2):217-225. PubMed ID: 38837773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.